Form 6-K NEOVASC INC For: Feb 22 - StreetInsider.com

Form 6-K NEOVASC INC For: Feb 22  StreetInsider.com

This Amended and Restated Management's Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) covers the unaudited amended ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more